WCLC 2026: The Presentations That May Shape The Future of NSCLC

Experts in thoracic oncology have convened at Seoul, South Korea, to share critical advances in the treatment of patients with lung cancer as part of the IASLC 2026 World Conference on Lung Cancer (WCLC). Of note, this year’s sessions have seen plenty of clinical trial updates and accompanying clinical implications in the realm of non–small cell lung cancer (NSCLC), as novel regimens continue to show benefit across different lines of treatment settings.